Fresenius Delayed By FDA Inspection Uncertainty As It Works Towards US Pegfilgrastim Launch
Biosimilars Head Ali Ahmed Talks About Company’s Biosimilars Strategy
Ahmed said the upcoming pegfilgrastim launch was “an important milestone for the company” • Source: Fresenius Kabi 
